Revival of anti-angiogenic therapies in cancer Andreas Pircher editorial 27 February 2018 Pages: 1 - 2
Uro-oncology 2018: new horizons, new treatment options, improved patient outcomes Ursula M. Vogl editorial 23 February 2018 Pages: 3 - 4
In need of special care: adolescent and young adult patients with cancer Michael N. Dworzak editorial 02 March 2018 Pages: 5 - 6
Targeting angiogenesis in lung cancer Sameh DaherJair Bar short review 23 February 2018 Pages: 9 - 13
Anti-angiogenic therapies in brain metastases Anna S. BerghoffMatthias Preusser short review Open access 02 February 2018 Pages: 14 - 17
Antiangiogenic therapies in ovarian cancer Adriaan VandersticheleSiel OlbrechtIgnace Vergote short review 23 February 2018 Pages: 18 - 26
My burning issues in the neoadjuvant treatment for breast cancer Elisabeth S. BergenRupert Bartsch review Open access 22 December 2017 Pages: 27 - 30
My burning issues in TKI therapy and treatment-free remission in CML Dominik Wolf editorial 21 December 2017 Pages: 31 - 32
Practice-changing developments in early use of chemohormonal therapy in metastatic prostate cancer Peter Horak short review 21 February 2018 Pages: 33 - 37
Local therapy of stage IV renal cell cancer: a case report Muna FernerAndrea Vera KeckKathrin Strasser-Weippl case report 08 January 2018 Pages: 38 - 42
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients Irene ReschShahrokh F. ShariatKilian M. Gust short review Open access 08 March 2018 Pages: 43 - 46
Adolescents and young adults with acute lymphoblastic leukemia and acute myeloid leukemia Mirella AmpatzidouCharikleia KelaidiSophia Polychronopoulou review 02 August 2017 Pages: 47 - 53
Novel guidelines on surveillance for breast cancer, cardiomyopathy, male gonadotoxicity, and premature ovarian insufficiency from the PanCare and International Guideline Harmonization Group on long-term follow-up after cancer in childhood Edit BardiLeo Kager review 21 February 2018 Pages: 54 - 58
Short overview on the current standard of treatment in newly diagnosed multiple myeloma Ella WillenbacherAgnes BalogWolfgang Willenbacher short review Open access 21 February 2018 Pages: 59 - 64
Cell free nucleic acids as diagnostic and prognostic marker in leukemia Maryam EiniSeyed Ali NojoumiAbbas Khosravi review 20 September 2017 Pages: 65 - 70
Pleural effusion in 11:14 translocation q1 multiple myeloma in the setting of proteasome inhibitor presents therapeutic complexity Malik GhannamMaria BryanBrent Berry case report Open access 21 February 2018 Pages: 71 - 76
ESMO 2017—my personal highlights Barbara KiesewetterMircea DediuRupert Bartsch comment Open access 16 February 2018 Pages: 77 - 79
Correction to: Report from the WCLC 2017 Congress, Yokohama, 15th–18th October, 2017 Springer-Verlag GmbH Austria Publisher Correction 21 February 2018 Pages: 80 - 80